Here's Why I'm Avoiding AstraZeneca Stock

The AZN affair exposes the seedy underbelly of drug manufacturing, and the COVID-19 vaccine is certainly a drug.

Biohaven Pharmaceutical Still Looks Unattractive Based on Its Charts

The migraine drugmaker has been sending weak technical signals for a few months now.

Here's Why I'm Selling Teladoc Health

Volume has picked up dramatically since a selloff in the online health services provider began, and it could get worse.

Let's Try Again on Walgreens Boots Alliance

I hate chasing a stock but it looks like I need to get with the program.

I Like the Growth Prospects for TeleHealth Stock LifeMD

Since we don't have a breakout, I would stay with a half-size approach on any trade here.

Is There Enough Technical Evidence to Go Long Peloton?

Let's see if it's time to jump back on the bike.

Looking at Bristol-Myers Again as the Quants Downgrade It

At current levels BMY is sort-of in no man's land - not bullish and not bearish.

Biotech CEL-SCI Needs More Base Building

Let's review the charts and indicators.

Dividend Hunters Will Like the Combination Found in Global Medical REIT Shares

More people seeking more healthcare and medical attention will create a rising tide for GMRE's addressable market.

Walgreens Boots Alliance Is Likely to Weaken Further

Let's check out the charts and indicators.